Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels. - Kurth I; Yamaguchi N; Andreu-Agullo C; Tian HS; Sridhar S; Takeda S; Gonsalves FC; Loo JM; Barlas A; Manova-Todorova K; Busby R; Bendell JC; et al. (Science advances, 2021)